Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Jul 03, 2020 5:56pm

127 Views

Post# 31222585

todays trades

House Positions for C:VXL from 20200703 to 20200703

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	157,200	13,362	0.085	57,000	4,845	0.085	100,200	-8,517
7 TD Sec	194,100	16,350	0.084	117,830	9,869	0.084	76,270	-6,481
85 Scotia	100,000	8,500	0.085	66,100	5,618	0.085	33,900	-2,882
68 Leede	0			1,000	87	0.087	-1,000	87
79 CIBC	830	74	0.089	5,000	425	0.085	-4,170	351
33 Canaccord	3,000	240	0.08	13,000	1,105	0.085	-10,000	865
19 Desjardins	0			20,000	1,700	0.085	-20,000	1,700
9 BMO Nesbitt	10,000	850	0.085	55,000	4,675	0.085	-45,000	3,825
2 RBC	46,000	3,960	0.086	176,200	15,012	0.085	-130,200	11,052
TOTAL	511,130	43,336	0.085	511,130	43,336	0.085	0	0